Moderna's (NASDAQ: MRNA) success story is all about its coronavirus vaccine. This is big -- especially considering Moderna didn't have any commercialized products until regulators authorized the vaccine in late December. Investors are hoping this is just the beginning of Moderna's coronavirus vaccine revenue growth.
Analysts had expected the Tesla CEO or the 'Dogefather' to mention the meme-inspired crypto on SNL and send prices spiking, instead his plug saw the coin crash nearly 25% from $0.69 to $0.48.
The Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to aid poor countries will not hand sensitive U.S. biopharmaceutical technology to China and Russia, responding to a chorus of concerns, U.S. and industry officials say. President Joe Biden on Wednesday backed the U.S. entering negotiations at the World Trade Organization for the waiver of intellectual property rights as a means to boost vaccine supplies by allowing poorer countries to make their own.